001     60251
005     20200402210441.0
024 7 _ |2 pmid
|a pmid:17964867
024 7 _ |2 DOI
|a 10.1016/j.bbapap.2007.09.005
024 7 _ |2 WOS
|a WOS:000252238600012
037 _ _ |a PreJuSER-60251
041 _ _ |a eng
082 _ _ |a 570
084 _ _ |2 WoS
|a Biochemistry & Molecular Biology
084 _ _ |2 WoS
|a Biophysics
100 1 _ |a Strucksberg, K.H.
|b 0
|u FZJ
|0 P:(DE-Juel1)VDB72839
245 _ _ |a Reversible and irreversible unfolding of multi-domain proteins
260 _ _ |a Amsterdam [u.a.]
|b Elsevier
|c 2007
300 _ _ |a 1501 - 1603
336 7 _ |a Journal Article
|0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
440 _ 0 |a BBA - Proteins and Proteomics
|x 1570-9639
|0 19421
|v 1774
500 _ _ |a Record converted from VDB: 12.11.2012
520 _ _ |a In contrast to single-domain proteins unfolding of larger multi-domain proteins is often irreversible. In a comparative case study on three different multi-domain proteins (phosphoglycerate kinase: PGK and two homologous alpha-amylases: TAKA and BLA) we investigated properties of unfolded states and their ability to fold back into the native state. For this purpose guanidine hydrochloride, alkaline pH, and thermal unfolded states were characterized. Structural alterations upon unfolding and refolding transitions were monitored using fluorescence and CD spectroscopy. Static and dynamic light scattering was employed to follow aggregation processes. Furthermore, proper refolding was also investigated by enzyme activity measurements. While for PGK at least partial reversible unfolding transitions were observed in most cases, we found reversible unfolding for TAKA in the case of alkaline pH and GndHCl induced unfolding. BLA exhibits reversible unfolding only under conditions with high concentrations of protecting osmolytes (glycerol), indicating that aggregation of the unfolded state is the main obstacle to achieve proper refolding for this protein. Structural properties, such as number and size of domains, secondary structure contents and compositions within domains, and domain topology were analyzed and considered in the interpretation of differences in refolding behavior of the investigated proteins.
536 _ _ |a Funktion und Dysfunktion des Nervensystems
|c P33
|2 G:(DE-HGF)
|0 G:(DE-Juel1)FUEK409
|x 0
588 _ _ |a Dataset connected to Web of Science, Pubmed
650 _ 2 |2 MeSH
|a Aspergillus oryzae: enzymology
650 _ 2 |2 MeSH
|a Bacillus: enzymology
650 _ 2 |2 MeSH
|a Buffers
650 _ 2 |2 MeSH
|a Glycerol: pharmacology
650 _ 2 |2 MeSH
|a Guanidine: pharmacology
650 _ 2 |2 MeSH
|a Hydrogen-Ion Concentration
650 _ 2 |2 MeSH
|a Models, Molecular
650 _ 2 |2 MeSH
|a Osmolar Concentration
650 _ 2 |2 MeSH
|a Phosphoglycerate Kinase: chemistry
650 _ 2 |2 MeSH
|a Protein Denaturation: drug effects
650 _ 2 |2 MeSH
|a Protein Folding
650 _ 2 |2 MeSH
|a Protein Structure, Tertiary: drug effects
650 _ 2 |2 MeSH
|a Protein Structure, Tertiary: physiology
650 _ 2 |2 MeSH
|a Temperature
650 _ 2 |2 MeSH
|a Transition Temperature
650 _ 2 |2 MeSH
|a alpha-Amylases: chemistry
650 _ 7 |0 0
|2 NLM Chemicals
|a Buffers
650 _ 7 |0 113-00-8
|2 NLM Chemicals
|a Guanidine
650 _ 7 |0 56-81-5
|2 NLM Chemicals
|a Glycerol
650 _ 7 |0 EC 2.7.2.3
|2 NLM Chemicals
|a Phosphoglycerate Kinase
650 _ 7 |0 EC 3.2.1.1
|2 NLM Chemicals
|a alpha-Amylases
650 _ 7 |a J
|2 WoSType
653 2 0 |2 Author
|a alpha-amylase
653 2 0 |2 Author
|a aggregation
653 2 0 |2 Author
|a unfolded states
653 2 0 |2 Author
|a protecting osmolyte
653 2 0 |2 Author
|a hydrodynamic radius
700 1 _ |a Rosenkranz, T.
|b 1
|u FZJ
|0 P:(DE-Juel1)VDB72840
700 1 _ |a Fitter, J.
|b 2
|u FZJ
|0 P:(DE-Juel1)131961
773 _ _ |a 10.1016/j.bbapap.2007.09.005
|g Vol. 1774, p. 1501 - 1603
|p 1501 - 1603
|q 1774<1501 - 1603
|0 PERI:(DE-600)2209540-8
|t Biochimica et biophysica acta / Proteins and proteomics
|v 1774
|y 2007
|x 1570-9639
856 7 _ |u http://dx.doi.org/10.1016/j.bbapap.2007.09.005
909 C O |o oai:juser.fz-juelich.de:60251
|p VDB
913 1 _ |k P33
|v Funktion und Dysfunktion des Nervensystems
|l Funktion und Dysfunktion des Nervensystems
|b Gesundheit
|0 G:(DE-Juel1)FUEK409
|x 0
914 1 _ |y 2007
915 _ _ |0 StatID:(DE-HGF)0010
|a JCR/ISI refereed
920 1 _ |k INB-2
|l Molekulare Biophysik
|d 31.12.2008
|g INB
|0 I:(DE-Juel1)VDB805
|x 0
970 _ _ |a VDB:(DE-Juel1)94481
980 _ _ |a VDB
980 _ _ |a ConvertedRecord
980 _ _ |a journal
980 _ _ |a I:(DE-Juel1)ISB-2-20090406
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
981 _ _ |a I:(DE-Juel1)IBI-7-20200312
981 _ _ |a I:(DE-Juel1)ISB-2-20090406
981 _ _ |a I:(DE-Juel1)ICS-6-20110106


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21